Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Net Debt / (EBITDA-CAPEX)

Adverum Biotechnlgs Net Debt / (EBITDA-CAPEX) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Net Debt / (EBITDA-CAPEX) from 2013 to 2020.
  • Adverum Biotechnlgs Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $2m a 23.50% increase of 0m year over year
  • Adverum Biotechnlgs Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $2m a 11.42% increase of 0m year over year
  • Adverum Biotechnlgs Annual Net Debt / (EBITDA-CAPEX) for 2019 was $2m a -69.40% decrease of -1m from 2018
  • Adverum Biotechnlgs Annual Net Debt / (EBITDA-CAPEX) for 2018 was $3m a -17.93% decrease of -1m from 2017
  • Adverum Biotechnlgs Annual Net Debt / (EBITDA-CAPEX) for 2017 was $3m a -32.75% decrease of -1m from 2016
Other Ratios Metrics:
  • Adverum Biotechnlgs Total Debt / Capital for the quarter ending December 12, 2017 was $0m a 56.92% increase of 0m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Debt / Equity for the quarter ending December 12, 2017 was $0m a 56.98% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Net Debt / (EBITDA-CAPEX) Data

06/2020$2m
03/2020$3m
12/2019$1m
09/2019$2m
06/2019$2m
03/2019$3m
12/2018$3m
09/2018$3m
06/2018$3m
03/2018$3m

Annual ADVM Net Debt / (EBITDA-CAPEX) Data

2019$2m
2018$3m
2017$3m
2016$4m
2015$6m
2014$6m
2013$0m
2012$0m